Literature DB >> 17767195

Role of telomeres and telomerase in genomic instability, senescence and cancer.

Yibin Deng1, Sandy Chang.   

Abstract

Telomeres are ribonucleoprotein structures that protect the end of linear chromosomes from recognition as DNA double-stranded breaks and activation of a DNA damage response. Telomere-associated proteins also regulate telomerase, the protein responsible for maintaining telomere length. Loss of telomere function results from either alteration in the capping function at telomeres, or from progressive loss of telomeric repeats necessary to maintain proper telomeric structure. Dysfunctional telomeres activate p53 to initiate cellular senescence or apoptosis to suppress tumorigenesis. However, in the absence of p53, telomere dysfunction is an important mechanism to generate chromosomal instability commonly found in human carcinomas. Telomerase is expressed in the majority of human cancers, making it an attractive therapeutic target. Emerging anti-telomerase therapies that are currently in clinical trials might prove useful against some forms of human cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17767195     DOI: 10.1038/labinvest.3700673

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  32 in total

Review 1.  The non-canonical functions of telomerase: to turn off or not to turn off.

Authors:  Aleksandra Romaniuk; Anna Paszel-Jaworska; Ewa Totoń; Natalia Lisiak; Hanna Hołysz; Anna Królak; Sylwia Grodecka-Gazdecka; Błażej Rubiś
Journal:  Mol Biol Rep       Date:  2018-11-17       Impact factor: 2.316

2.  Targeted polytherapy in small cell sarcoma and its association with doxorubicin.

Authors:  S N Dumont; D Yang; A G Dumont; D Reynoso; J-Y Blay; J C Trent
Journal:  Mol Oncol       Date:  2014-06-10       Impact factor: 6.603

3.  Elevated TRF2 in advanced breast cancers with short telomeres.

Authors:  Malissa C Diehl; Michael O Idowu; Katherine N Kimmelshue; Timothy P York; Colleen K Jackson-Cook; Kristi C Turner; Shawn E Holt; Lynne W Elmore
Journal:  Breast Cancer Res Treat       Date:  2010-07-13       Impact factor: 4.872

4.  Human telomeric DNA sequences are a major target for the antitumour drug bleomycin.

Authors:  Trung V Nguyen; Vincent Murray
Journal:  J Biol Inorg Chem       Date:  2011-07-15       Impact factor: 3.358

5.  Cancer gene therapy by NF-κB-activated cancer cell-specific expression of CRISPR/Cas9 targeting telomeres.

Authors:  Wei Dai; Jian Wu; Danyang Wang; Jinke Wang
Journal:  Gene Ther       Date:  2020-02-07       Impact factor: 5.250

6.  HTERT MNS16A polymorphism in breast cancer: a case-control study.

Authors:  Flora Zagouri; Theodoros N Sergentanis; Maria Gazouli; Alexandra Tsigginou; Constantine Dimitrakakis; Evaggelos Eleutherakis-Papaiakovou; Irene Papaspyrou; Dimosthenis Chrysikos; George Theodoropoulos; George C Zografos; Aris Antsaklis; Athanassios-Meletios Dimopoulos; Christos A Papadimitriou
Journal:  Mol Biol Rep       Date:  2012-10-12       Impact factor: 2.316

7.  Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma.

Authors:  Gabriella M Anic; Vernon K Sondak; Jane L Messina; Neil A Fenske; Jonathan S Zager; Basil S Cherpelis; Ji-Hyun Lee; William J Fulp; Pearlie K Epling-Burnette; Jong Y Park; Dana E Rollison
Journal:  Cancer Epidemiol       Date:  2013-03-21       Impact factor: 2.984

8.  Expression pattern of hTERT telomerase subunit gene in different stages of chronic myeloid leukemia.

Authors:  Ali Amini; Seyed Hamidollah Ghaffari; Yousef Mortazavi; Yousef Mortazai; Karim Daliri; Shahrouz Taranejoo; Kamran Alimoghadam; Ardeshir Ghavamzadeh
Journal:  Mol Biol Rep       Date:  2014-09       Impact factor: 2.316

9.  Genetic variation exists for telomeric array organization within and among the genomes of normal, immortalized, and transformed chicken systems.

Authors:  Thomas H O'Hare; Mary E Delany
Journal:  Chromosome Res       Date:  2009-11-05       Impact factor: 5.239

Review 10.  Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  J Cell Mol Med       Date:  2009-09-01       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.